Libing Hu Selected Research

KT 5720

10/2021

The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Libing Hu Research Topics

Disease

5	Neoplasms (Cancer) 12/2021 - 11/2007
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 11/2007
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Necrosis 12/2017
1	Prostatic Neoplasms (Prostate Cancer) 12/2017

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2007
1	Versicans (Versican)IBA 01/2023
1	Conditioned Culture MediaIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	VimentinIBA 01/2023
1	CytokinesIBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2023
1	Long Noncoding RNAIBA 12/2021
1	Gemcitabine FDA Link 12/2021
1	Competitive Endogenous RNAIBA 12/2021
1	Caspase 3 (Caspase-3)IBA 12/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 10/2021
1	KT 5720IBA 10/2021
1	Sunitinib (Sutent)FDA Link 10/2021
1	Parathyroid Hormone-Related ProteinIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2017
1	Messenger RNA (mRNA)IBA 12/2017
1	Testosterone (Sustanon)FDA Link 12/2017
1	Aromatase (CYP19)IBA 12/2017
1	AndrogensIBA 12/2017
1	GANT 61IBA 12/2017
1	EnzymesIBA 12/2017
1	ResveratrolIBA 02/2017
1	Antineoplastic Agents (Antineoplastics)IBA 02/2017
1	Matrix Metalloproteinases (MMPs)IBA 02/2017
1	ChromatinIBA 11/2007